Prospective Evaluation of an Endoscopic Ultrasound (EUS)-Based Artificial Intelligence to Assist in the Deployment of Lumen Apposing Metal Stents for Gallbladder Drainage
EUS-AI GBD
1 other identifier
observational
38
1 country
1
Brief Summary
Lumen apposing metal stents are now being used to help patients who suffer from cholecystitis (infection of the gallbladder), especially in cases where patients are not candidates for surgery. Lumen apposing metal stents are effective for draining the gallbladder, however, placement is technically challenging. Scientists have developed an artificial intelligence to aid doctors in the deployment of these stents into the gallbladder. The aim of this study is test the performance of an artificial intelligence in providing physicians accurate information for gallbladder drainage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2025
CompletedStudy Start
First participant enrolled
May 12, 2025
CompletedFirst Posted
Study publicly available on registry
May 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMarch 17, 2026
March 1, 2026
8 months
April 24, 2025
March 13, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Accuracy of the EUS AI system in providing a recommendation (i.e. whether it is safe or not to drain the gallbladder)
An expert endoscopist will perform the endoscopic ultrasound procedure. When the gallbladder comes into view the expert will comment as to whether they believe that the gallbladder is safe to drain. The expert will be blinded to the AI computers interpretation of the view of the gallbladder. A second observer will record what the AI recommended at the time of the blinded expert. The expert will be considered the "gold standard" and the outcome will be accuracy of the AI in mimicking the experts recommendations.
Day 1
Study Arms (1)
Patients with gallbladders undergoing AI evaluation for stent deployment
Eligibility Criteria
Patients undergoing endoscopic ultrasound who have a gallbladder present
You may qualify if:
- Age ≥ 18 years old
- Anticipation that patient may undergo endoscopic ultrasound
- Gallbladder present
You may not qualify if:
- Cholecystectomy
- No indication for endoscopic ultrasound
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UMass Chan Medical School/Umass Memorial Health Care
Worcester, Massachusetts, 01655, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Clinical Professor of Medicine
Study Record Dates
First Submitted
April 24, 2025
First Posted
May 20, 2025
Study Start
May 12, 2025
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
March 17, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
Other researchers can reach out to UMass Chan to obtain deidentified data on a case-by-case basis.